/product/75/9455914/1.jpg?6587)
Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The molecular explanation involves multiple synergistic pathways
The peptide operates through several identified mechanisms including upregulation of growth hormone receptors, activation of the FAK-paxillin pathway essential for cell migration, promotion of angiogenesis through VEGF modulation, and interaction with the nitric oxide system
It should not be used in neonates, pregnant women, certain medications, or for intrathecal injection
Table of Contents CJC-1295 + Ipamorelin (Growth Hormone Axis Support) Why Its Popular for Muscle Research CJC-1295 and Ipamorelin are frequently studied together due to their complementary roles in growth hormone pathway signaling
Dosing starts at 0.25 mg and titrates to a full adult dose of 2.4 mg
The compound is not classified as a controlled substance, but selling it as a health product violates Canadian law
